🇺🇸 FDA
Pipeline program

COBI

GS-US-216-0114

Phase 3 small_molecule completed

Quick answer

COBI for HIV is a Phase 3 program (small_molecule) at Gilead Sciences Ireland UC with 1 ClinicalTrials.gov record(s).

Program details

Company
Gilead Sciences Ireland UC
Indication
HIV
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials